Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT00838955
Title Temsirolimus for Relapsed/Refractory Hodgkin's Lymphoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Loyola University

Hodgkin's lymphoma



Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Loyola Univeristy Medical Center, Cardinal Bernardin Cancer Center Maywood Illinois 60153 United States Details
*Shaded cells indicate that there was no data available from for the field